News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
402,036 Results
Type
Article (26508)
Company Profile (67)
Press Release (375461)
Section
Business (114704)
Career Advice (445)
Deals (19318)
Drug Delivery (40)
Drug Development (50531)
Employer Resources (47)
FDA (12793)
Job Trends (8700)
News (202881)
Policy (21058)
Tag
Academia (1764)
Africa (391)
Allergies (35)
Alliances (30536)
Alzheimer's disease (700)
Approvals (12749)
Arizona (80)
Artificial intelligence (43)
Asia (33848)
Australia (4922)
Bankruptcy (140)
Best Places to Work (6820)
Biotechnology (45)
Breast cancer (42)
C2C Services and Suppliers (59377)
California (1007)
Canada (599)
Cancer (336)
Career advice (404)
Cell therapy (64)
China (103)
Clinical research (41191)
Collaboration (76)
Colorado (45)
Connecticut (46)
COVID-19 (1481)
Data (234)
Diabetes (54)
Diagnostics (3463)
Drug pricing (40)
Earnings (39308)
Employer resources (43)
Europe (52888)
Events (52911)
Executive appointments (103)
FDA (12971)
Florida (177)
Funding (82)
Gene therapy (34)
Georgia (35)
GLP-1 (290)
Government (3048)
Healthcare (12437)
Hotbed/Location (262244)
Idaho (33)
Illinois (167)
Indiana (100)
Infectious disease (1495)
Inflammatory bowel disease (67)
Interviews (37)
IPO (7744)
Job creations (1972)
Job search strategy (379)
Kansas (67)
Layoffs (151)
Legal (4203)
Liver cancer (48)
Lung cancer (85)
Manufacturing (33)
Maryland (310)
Massachusetts (723)
Medical device (12675)
Medtech (12679)
Mergers & acquisitions (11565)
Metabolic disorders (159)
Michigan (52)
Minnesota (144)
Neuroscience (785)
New Hampshire (46)
New Jersey (362)
New York (331)
NextGen Class of 2024 (4007)
Non-profit (2822)
North Carolina (349)
Northern California (471)
Obesity (99)
Ohio (63)
Opinion (59)
Patents (41)
Pennsylvania (356)
People (35915)
Phase I (11726)
Phase II (17835)
Phase III (14656)
Pipeline (70)
Postmarket research (1755)
Preclinical (3786)
Rare diseases (62)
Real estate (3214)
Regulatory (14465)
Research institute (1626)
Resumes & cover letters (48)
South America (563)
Southern California (430)
Startups (2308)
Texas (153)
United States (4885)
Vaccines (247)
Washington State (86)
Weight loss (86)
Date
Today (83)
Last 7 days (454)
Last 30 days (1481)
Last 365 days (22310)
2024 (15534)
2023 (24075)
2022 (32786)
2021 (35122)
2020 (34394)
2019 (29943)
2018 (23049)
2017 (20515)
2016 (19612)
2015 (23129)
2014 (17578)
2013 (14710)
2012 (15832)
2011 (16248)
2010 (14815)
402,036 Results for "syneron medical ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
Business
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, reported its financial results for the fiscal year ended December 31, 2023.
April 24, 2024
·
14 min read
Press Releases
WORK Medical Technology Group LTD Announces Pricing of Initial Public Offering
August 26, 2024
·
5 min read
Press Releases
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
September 12, 2024
·
4 min read
Press Releases
SEED Therapeutics Appoints Eisai Co., Ltd.’s Dr. Yoshiharu Mizui to Board of Directors
September 12, 2024
·
2 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Press Releases
Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China
August 12, 2024
·
3 min read
Bioretec Ltd’s business review January-March 2024: Controlled launch in the U.S. progresses
This announcement summarizes Bioretec Ltd’s business review for January-March 2024.
May 16, 2024
·
6 min read
Deals
Specac, Ltd Acquires Harrick Scientific
Specac, Ltd announced today the acquisition of Harrick Scientific, Inc.
April 2, 2024
·
3 min read
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems.
June 12, 2024
·
5 min read
1 of 40,204
Next
